202 related articles for article (PubMed ID: 28939099)
21. Clinicopathological and prognostic significance of the RUNX3 expression in gastric cancer: a systematic review and meta-analysis.
Liu B; Han Y; Jiang L; Jiang D; Li W; Zhang T; Zu G; Zhang X
Int J Surg; 2018 May; 53():122-128. PubMed ID: 29578091
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of Muc5AC in gastric cancer: A meta-analysis.
Zhang CT; He KC; Pan F; Li Y; Wu J
World J Gastroenterol; 2015 Sep; 21(36):10453-60. PubMed ID: 26420972
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological and prognostic value of S100A4 expression in gastric cancer: a meta-analysis.
Ling Z; Li R
Int J Biol Markers; 2014 Jun; 29(2):e99-e111. PubMed ID: 24242292
[TBL] [Abstract][Full Text] [Related]
24. The prognostic value of pSTAT3 in gastric cancer: a meta-analysis.
Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y
J Cancer Res Clin Oncol; 2016 Mar; 142(3):649-57. PubMed ID: 26233579
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
26. Dysregulated Expression Levels of Circular RNAs Serve as Prognostic and Clinicopathological Markers in Gastric Cancer: a Meta-Analysis.
Zhao G; Wu Y; Wu L; Huang J; Gan Y; Li H
Clin Lab; 2021 Apr; 67(4):. PubMed ID: 33865259
[TBL] [Abstract][Full Text] [Related]
27. The clinicopathological and prognostic significance of PD-L1 expression in gastric cancer: a meta-analysis of 10 studies with 1,901 patients.
Zhang M; Dong Y; Liu H; Wang Y; Zhao S; Xuan Q; Wang Y; Zhang Q
Sci Rep; 2016 Nov; 6():37933. PubMed ID: 27892511
[TBL] [Abstract][Full Text] [Related]
28. Vimentin immunohistochemical expression as a prognostic factor in gastric cancer: A meta-analysis.
Yin S; Chen FF; Yang GF
Pathol Res Pract; 2018 Sep; 214(9):1376-1380. PubMed ID: 30078472
[TBL] [Abstract][Full Text] [Related]
29. Poor prognosis of phosphatase of regenerating liver 3 expression in gastric cancer: a meta-analysis.
Hu L; Luo H; Wang W; Li H; He T
PLoS One; 2013; 8(10):e76927. PubMed ID: 24204707
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathologic and prognostic significance of human epidermal growth factor receptor in patients with gastric cancer: An updated meta-analysis.
Zhang Z; Tang H; Lin J; Hu Y; Luo G; Luo Z; Cheng C; Wang P
Oncotarget; 2017 Mar; 8(10):17202-17215. PubMed ID: 28199988
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA PCAT-1 in human cancers: A meta-analysis.
Liang C; Qi Z; Ge H; Liang C; Zhang Y; Wang Z; Li R; Guo J
Clin Chim Acta; 2018 May; 480():47-55. PubMed ID: 29378170
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of epidermal growth factor receptor in patients with gastric cancer: a meta-analysis.
Hong L; Han Y; Yang J; Zhang H; Jin Y; Brain L; Li M; Zhao Q
Gene; 2013 Oct; 529(1):69-72. PubMed ID: 23954221
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological significance of HSP27 in gastric cancer: a meta-analysis.
Ge H; He X; Guo L; Yang X
Onco Targets Ther; 2017; 10():4543-4551. PubMed ID: 28979146
[TBL] [Abstract][Full Text] [Related]
34. Correlation of cadherin-17 protein expression with clinicopathological features and prognosis of patients with sporadic gastric cancer.
Meng W; Gu T; Gao LM; Zong ZG; Meng L; Fu ZZ; Guo L
Braz J Med Biol Res; 2015 Dec; 48(12):1077-86. PubMed ID: 26421870
[TBL] [Abstract][Full Text] [Related]
35. Relationships between abnormal MMP2 expression and prognosis in gastric cancer: a meta-analysis of cohort studies.
Wang HL; Zhou PY; Zhang Y; Liu P
Cancer Biother Radiopharm; 2014 May; 29(4):166-72. PubMed ID: 24784911
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological and prognostic significance of metastasis-associated in colon cancer-1 in gastric cancer: A meta-analysis.
Jin Y; Zhou K; Zhao W; Han R; Huo X; Yang F; Chen J
Int J Biol Markers; 2019 Mar; 34(1):27-32. PubMed ID: 30854927
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological and prognostic significance of FoxM1 in gastric cancer: A meta-analysis.
Jiang D; Jiang L; Liu B; Huang H; Li W; Zhang T; Zu G; Zhang X
Int J Surg; 2017 Dec; 48():38-44. PubMed ID: 29017864
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of DNA aneuploidy in gastric cancer: a meta-analysis of 3449 cases.
Xu J; Zhu R; Fan L; Ge S; Wei W; Li X; Da L; Jia Z; Zhao Z; Ning J; Da J; Peng W; Gu K; Sun G
BMC Cancer; 2019 Jul; 19(1):650. PubMed ID: 31266459
[TBL] [Abstract][Full Text] [Related]
39. Expression of vascular endothelial growth factor (VEGF)-C and -D in gastric carcinoma.
Shida A; Fujioka S; Kobayashi K; Ishibashi Y; Nimura H; Mitsumori N; Yanaga K
Int J Clin Oncol; 2006 Feb; 11(1):38-43. PubMed ID: 16508727
[TBL] [Abstract][Full Text] [Related]
40. CD44v6: A metastasis-associated biomarker in patients with gastric cancer?: A comprehensive meta-analysis with heterogeneity analysis.
Lu L; Huang F; Zhao Z; Li C; Liu T; Li W; Fu W
Medicine (Baltimore); 2016 Dec; 95(50):e5603. PubMed ID: 27977599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
